Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008)

Table 1 Number of centres contributing S. pneumoniae or H. influenzae isolates between 2004 and 2012

Region^a	2004	2005	2006	2007	2008	2009	2010	2011	2012	Total^b
Africa	1	4	4	6	2	2	0	1	8	16
Asia/ Pacific Rim	7	6	20	24	17	14	12	1	13	48
Europe	31	25	50	70	104	112	95	35	108	196
Latin America	4	13	22	24	35	29	15	6	25	59
Middle East	1	2	3	5	9	9	9	4	7	20
North America	70	110	99	92	45	43	32	23	80	221
Global	114	160	198	221	212	209	163	70	241	560

^aAfrica = Mauritius, Morocco, South Africa, Tunisia; Asia/Pacific Rim = Australia, China, Hong Kong, India, Malaysia, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand; Europe = Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, The Netherlands, United Kingdom; Latin America = Argentina, Brazil, Chile, Colombia, Guatemala, Honduras, Jamaica, Mexico, Panama, Venezuela; Middle East = Israel, Jordan, Kuwait, Lebanon, Oman, Saudi Arabia, Turkey; North America = Canada, United States.
^bTotal = the total number of unique centres contributing isolates between 2004 and 2012.

ISSN: 1476-0711